Filing Details
- Accession Number:
- 0001179110-15-009972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-17 17:18:21
- Reporting Period:
- 2015-06-15
- Filing Date:
- 2015-06-17
- Accepted Time:
- 2015-06-17 17:18:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537670 | A Scott Holmes | C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451 | Svp, Finance And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-06-15 | 1,346 | $66.63 | 51,958 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-15 | 2,734 | $14.89 | 54,692 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-15 | 3,500 | $16.55 | 58,192 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-15 | 6,234 | $66.63 | 51,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-06-15 | 2,734 | $0.00 | 2,734 | $14.89 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-06-15 | 3,500 | $0.00 | 3,500 | $16.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,375 | 2019-06-25 | No | 4 | M | Direct | |
| 11,500 | 2023-02-28 | No | 4 | M | Direct |
Footnotes
- The reported transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2015.
- This option vests and becomes exercisable over four years from the grant date (June 25, 2012), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.
- This option vests and becomes exercisable over four years from the grant date (February 28, 2013), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter.
Billionaire Hedge Funds
